TLDR
- ARK Invest purchased 34,080 shares of Meta Platforms (META) stock valued at $20.55 million on July 9, 2026
- The significant Meta acquisition occurred ahead of the company’s Q2 earnings announcement scheduled for July 29
- ARK offloaded 10,774 AMD shares worth $5.57 million, marking another week of position reduction
- The investment firm also added 217,896 Circle Internet Group shares across three ETFs totaling $13.96 million
- Analysts give Meta a Strong Buy consensus with an average target price of $817.15
Cathie Wood’s ARK Invest executed several significant portfolio adjustments on Thursday, July 9, 2026. The most notable transaction was a substantial $20.55 million acquisition of Meta Platforms stock through the ARK Innovation ETF.
The investment firm acquired 34,080 Meta shares. This strategic purchase was timed just weeks ahead of Meta’s scheduled second-quarter earnings release on July 29.
Analysts on Wall Street anticipate Meta will report earnings per share of $7.17 with quarterly revenue reaching $60.19 billion.
Meta’s AI Developments Drive ARK’s Investment Decision
The purchase followed several significant artificial intelligence announcements from Meta. The social media giant introduced Muse Spark 1.1, marking its first commercial AI model offering, alongside new AI-powered business tools.
Meta revealed that Iris, its proprietary AI chip, is scheduled for large-scale production beginning in September. Additionally, the company disclosed plans for a massive investment exceeding $13 billion in a new Alberta, Canada data center facility.
According to TipRanks, Meta receives a Strong Buy consensus rating from analysts, with 34 Buy recommendations and five Hold ratings. The average analyst price target of $817.15 suggests potential upside of approximately 29.4% from present levels. Meta shares have declined 4.2% year-to-date.
AMD Position Reduced Along with Other Tech Holdings
On the divestment side, ARK disposed of 10,774 Advanced Micro Devices shares through its ARKK ETF. The transaction generated $5.57 million. This represents a continued withdrawal from AMD, as ARK has been systematically reducing exposure over recent trading sessions.
ARK additionally sold 85,319 Robinhood Markets shares generating $9.69 million and 70,154 Roku shares for $9.77 million.
The firm also reduced its Twist Bioscience holdings, offloading 98,776 shares valued at $8.83 million.
Beyond the Meta purchase, ARK expanded its Circle Internet Group position. The firm acquired 217,896 shares distributed across its ARKK, ARKW, and ARKF ETFs, representing a combined investment of $13.96 million.
ARK also accumulated 105,364 Ionis Pharmaceuticals shares worth $8.9 million and 544,385 Prime Medicine shares valued at $2.52 million.
Additional smaller acquisitions included 57,462 Generate Biomedicines shares for $911,921 and 46,302 Compass Pathways shares for $646,838.
Meta stock climbed 6.58% on July 10, following the public disclosure of ARK’s substantial purchase.
